Clinical Protocol and Data Management
Clinical Protocol and Data Management
批准号:
7698841
负责人:
John David Roberts
金额:
$2.1万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-03 至 2011-04-30
关键词:
Biostatistics Shared ResourceCancer CenterCancer Therapy Evaluation ProgramClinical ProtocolsClinical ResearchClinical TrialsCommunicationContinuing EducationContractsDataDatabasesDevelopmentDisciplineGrantIndustryInformaticsInformation SystemsMaintenanceMissionMonitorNursing ResearchPhasePlayProgram DescriptionProtocols documentationReportingResearchResearch Ethics CommitteesResearch PersonnelResource SharingRoleSafetyServicesShared Resource Cancer CenterSorting - Cell MovementStandards of Weights and MeasuresSystemTranslational ResearchUnited States Food and Drug AdministrationUnited States National Institutes of Healthanticancer researchauthoritybench to bedsidecancer preventiondata managementprogramsquality assurance
中文摘要
临床方案和数据管理共享资源(CPDMSR)提供集中管理
以及协调、促进和报告癌症中心临床试验以及
支持质量保障机制。CPDMSR与共享的生物统计学密切协调
资源(BSR)、议定书审查和监测系统(PRMS)、数据和安全监测(DSM)、
癌症研究信息学和服务(CRIS)共享资源,以及癌症中心管理。
CPDMSR有四个组件:
?导演
?临床试验办公室(CTO)
10个研究小组(9个学科研究小组和1个地理研究小组)
?数据库管理。
这些构成部分通过以下服务协助调查人员:
发展和管理赞助商关系(赠款、合同、合规)
?遵守内部和外部监管机构(PRMS、IRB、NIH、CTEP、FDA等)
?通信
?关于临床研究中不断发展的实践和监管标准的继续教育
?研究护理和数据管理监督
?协议特定研究护理和数据管理
?开发和维护临床研究数据库(与
癌症研究信息学与服务共享资源(CRIS)--生物统计学共享
资源(BSR)和管理)。
英文摘要
The Clinical Protocol and Data Management Shared Resource (CPDMSR) provides central management
and oversight functions for coordinating, facilitating, and reporting on Cancer Center clinical trials as well as
support for quality assurance mechanisms. The CPDMSR coordinates closely with the Biostatistics Shared
Resource (BSR), the Protocol Review and Monitoring System (PRMS), Data and Safety Monitoring (DSM),
the Cancer Research Informatics and Services (CRIS) Shared Resource, and Cancer Center Administration.
CPDMSR has four components:
¿ Director
¿ Clinical Trials Office (CTO)
¿ Ten Research Teams (9 discipline-oriented and 1 geographic)
¿ Database Management.
These components assist investigators through the following services:
¿ Development and management of sponsor relations (grants, contracts, compliance)
¿ Compliance with internal and external regulatory authorities (PRMS, IRB, NIH, CTEP, FDA, etc.)
¿ Communications
¿ Continuing education with regard to evolving practice and regulatory standards in clinical research
¿ Research nursing and data management oversight
¿ Protocol specific research nursing and data management
¿ Development and maintenance of databases for clinical research (a collaborative effort with the
Cancer Research Informatics and Services Shared Resource (CRIS), the Biostatistics Shared
Resource (BSR), and Administration).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: COMBINED TREATMENT WITH BORTEZOMIB & DACARBAZINE
-
批准号:8166535
-
项目类别:
-
资助金额:$2.24万
-
财政年份:2009
-
负责人:John David Roberts
-
依托单位:
CLINICAL TRIAL: PILOT/PHASE 1 STUDY OF ZOLEDRONIC ACID (ZOMETA ) IN SICKLE CELL
-
批准号:7950882
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2008
-
负责人:John David Roberts
-
依托单位:
CLINICAL TRIAL: COMBINED TREATMENT WITH BORTEZOMIB & DACARBAZINE
-
批准号:7950860
-
项目类别:
-
资助金额:$3.22万
-
财政年份:2008
-
负责人:John David Roberts
-
依托单位:
CLINICAL TRIAL: NCI 6858: A PHASE 1 STUDY OF SUBEROYLANILIDE HYDROXAMIC ACID (S
-
批准号:7950875
-
项目类别:
-
资助金额:$2.43万
-
财政年份:2008
-
负责人:John David Roberts
-
依托单位:
CLINICAL TRIAL: A PHASE 2 STUDY OF AZD6244 IN ADVANCED OR METASTATIC HEPATOCELLU
-
批准号:7950892
-
项目类别:
-
资助金额:$1.4万
-
财政年份:2008
-
负责人:John David Roberts
-
依托单位:
CLINICAL TRIAL: NCI 6858: A PHASE 1 STUDY OF SUBEROYLANILIDE HYDROXAMIC ACID (S
-
批准号:7717049
-
项目类别:
-
资助金额:$0.91万
-
财政年份:2007
-
负责人:John David Roberts
-
依托单位:
CLINICAL TRIAL: COMBINED TREATMENT WITH BORTEZOMIB & DACARBAZINE
-
批准号:7717028
-
项目类别:
-
资助金额:$0.38万
-
财政年份:2007
-
负责人:John David Roberts
-
依托单位:
COMBINED TREATMENT WITH BORTEZOMIB & DACARBAZINE
-
批准号:7605017
-
项目类别:
-
资助金额:$1.47万
-
财政年份:2006
-
负责人:John David Roberts
-
依托单位:
NCI 6858: A PHASE 1 STUDY OF SUBEROYLANILIDE HYDROXAMIC ACID (SAHA) IN COMBI
-
批准号:7605042
-
项目类别:
-
资助金额:$1.9万
-
财政年份:2006
-
负责人:John David Roberts
-
依托单位:
BONE TURNOVER IN SICKLE CELL DISEASE
-
批准号:7605010
-
项目类别:
-
资助金额:$0.56万
-
财政年份:2006
-
负责人:John David Roberts
-
依托单位:
COMBINED TREATMENT WITH BORTEZOMIB & DACARBAZINE
-
批准号:7375157
-
项目类别:
-
资助金额:$3.29万
-
财政年份:2005
-
负责人:John David Roberts
-
依托单位:
BONE TURNOVER IN SICKLE CELL DISEASE
-
批准号:7375148
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2005
-
负责人:John David Roberts
-
依托单位:
COMBINED TREATMENT WITH BORTEZOMIB & DACARBAZINE
-
批准号:7201520
-
项目类别:
-
资助金额:$0.04万
-
财政年份:2004
-
负责人:John David Roberts
-
依托单位:
Modulation of the Bio. Response to IL-2 with Bryostatin
-
批准号:7040921
-
项目类别:
-
资助金额:$4.33万
-
财政年份:2003
-
负责人:John David Roberts
-
依托单位:
CORE--CLINICAL PROTOCOL AND DATA MANAGEMENT
-
批准号:6592801
-
项目类别:
-
资助金额:$4.12万
-
财政年份:2002
-
负责人:John David Roberts
-
依托单位:
PHASE 1 TRIAL OF BRYOSTATIN AND INTERLEUKIN-2
-
批准号:6087104
-
项目类别:
-
资助金额:$14.18万
-
财政年份:2000
-
负责人:John David Roberts
-
依托单位:
VCU MINORITY-BASED CCOP
-
批准号:6375883
-
项目类别:
-
资助金额:$45.93万
-
财政年份:2000
-
负责人:John David Roberts
-
依托单位:
VCU MINORITY-BASED CCOP
-
批准号:6754374
-
项目类别:
-
资助金额:$46.31万
-
财政年份:2000
-
负责人:John David Roberts
-
依托单位:
VCU MINORITY-BASED CCOP
-
批准号:6633035
-
项目类别:
-
资助金额:$42.93万
-
财政年份:2000
-
负责人:John David Roberts
-
依托单位:
CORE--CLINICAL RESEARCH
-
批准号:6300072
-
项目类别:
-
资助金额:$4.12万
-
财政年份:2000
-
负责人:John David Roberts
-
依托单位:
海外基金